Magdalena Biosciences

About Magdalena Biosciences

Magdalena Biosciences is a joint venture between Jaguar Health and Filament Health, focused on developing novel, prescription medicines derived from plants for mental health indications. Their mission is to achieve a paradigm shift in drug development, targeting a timeline of 12-24 months from project commencement to human proof-of-concept studies, leveraging centuries of medicinal plant use to increase the likelihood of safe and efficacious FDA-approved botanical drugs.

Products & Services

Botanical Drugs for Mental Health:Developing FDA-approved drugs for daily use, initially focusing on improving executive dysfunction in ADHD and cognitive deficits in schizophrenia.

Drug Pipeline:Pipeline of IND-enabled drugs targeting ADHD, schizophrenia, anxiety, and depression.

Specialties

Plant-derived Medicines Mental Health Treatments FDA Botanical Drug Development ADHD and Schizophrenia Treatments

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Seed T: - FT: Seed	A: 1000000 MR: - FA: US$1,000,000 FAN: 1000000	D: 2023-10-30 FD: 2023-10-30	1 investors

Seed Latest

2023-10-30

$1.0M

1 investor (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

K

Karen J. Brunke

Acting CEO

S

Steven R. King

ETHNOBOTANICAL RESEARCH AND SUSTAINABLE SUPPLY ADVISOR

E

Elaine Elisabetsky

Advisor

L

Lisa Ranken

Advisor

R

Ryan Moss

Advisor

W

Warren Duncan

Advisor

View 7 more team members with Pro

Unlock Full Team Directory

Recent News